Renal carcinomas (RCC) are divided into several subtypes, defined by histological, genetic and phenotypic criteria. The differential diagnosis of these tumors is important with prognostic and therapeutic implications. Genetics and diagnosis: We studied the clinical, histological, immunohistochemical and genetic of papillary RCC (PRCC) type 1...
-
December 18, 2015 (v1)PublicationUploaded on: February 28, 2023
-
December 2023 (v1)Journal article
Abstract The prognosis of renal cell carcinoma (RCC) malignant neoplasms deeply relies on an accurate determination of the histological subtype, which currently involves the light microscopy visual analysis of histological slides, considering notably tumor architecture and cytology. RCC subtyping is therefore a time-consuming and tedious...
Uploaded on: November 25, 2023 -
September 22, 2022 (v1)Conference paper
Vascular network analysis is crucial to define the tumoral architecture and then diagnose the cancer subtype. However, automatic vascular network segmentation from Hematoxylin and Eosin (H&E) staining histopathological images is still a challenge due to the background complexity. Moreover, there is a lack of large manually annotated vascular...
Uploaded on: February 22, 2023 -
September 27, 2021 (v1)Conference paper
Renal Cell Carcinoma (RCC) is one of the most common malignancies, and pathological diagnosis is the most reliable RCC diagnostic method. Recognizing the type of RCC tumor and the possibility of cell migration highly depends on the geometric and topological properties of the vascular network. Motivated by the diagnosis pipeline, we explore the...
Uploaded on: December 4, 2022 -
June 15, 2016 (v1)Conference paper
The renal cell carcinoma (RCC) is the most frequent type of kidney cancer (between 90% and 95%). Twelve subtypes of RCC can be distinguished, among which the clear cell carcinoma (ccRCC) and the papillary carcinoma (pRCC) are the two most common ones (75% and 10% of the cases, respectively). After resection (i.e., surgical removal), the tumor...
Uploaded on: February 28, 2023 -
October 3, 2021 (v1)Journal article
Purpose: The histopathological images contain a huge amount of information, which can make diagnosis an extremely time-consuming and tedioustask. In this study, we developed a completely automated system to detect regions-of-interest (ROIs) in Whole Slide Images (WSI) of Renal Cell Carcinoma (RCC), to reduce time analysis and assist...
Uploaded on: December 4, 2022 -
2018 (v1)Journal article
Seven cases of translocation-associated renal cell carcinoma involving ALK (ALK-tRCC) were referenced in the last World Health Organization's classification (2016), in a group of emerging/provisional RCC. The first three cases were pediatric, medullary-based, associated with sickle cell trait and showed a fusion of ALK with VCL. Thirteen cases...
Uploaded on: December 4, 2022 -
November 2010 (v1)Journal article
Bevacizumab (Bvz), a Vascular Endothelial Growth Factor (VEGF)-targeted humanised monoclonal antibody, provides clinical benefit in combination with docetaxel (DXL), a microtubule-stabilising agent, in the treatment of metastatic breast and prostate cancers. Since VEGF and their receptors are expressed by tumour cells, we hypothesised that Bvz,...
Uploaded on: December 3, 2022 -
October 2013 (v1)Journal article
Background The differential diagnosis between infiltrative glioma (IG) and benign or curable glial lesions, such as gliosis, pilocytic astrocytoma, dysembryoplastic neuroepithelial tumor, ganglioglioma, or demyelinating disease, may be challenging for the pathologist because specific markers are lacking. Recently, we described a strong EGFR...
Uploaded on: December 2, 2022 -
May 27, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
October 2013 (v1)Journal article
Background The differential diagnosis between infiltrative glioma (IG) and benign or curable glial lesions, such as gliosis, pilocytic astrocytoma, dysembryoplastic neuroepithelial tumor, ganglioglioma, or demyelinating disease, may be challenging for the pathologist because specific markers are lacking. Recently, we described a strong EGFR...
Uploaded on: October 11, 2023 -
November 11, 2016 (v1)Conference paper
International audience
Uploaded on: December 4, 2022 -
November 2014 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
June 29, 2017 (v1)Publication
Head and neck cancers, the 7 th cause of death worldwide, are currently treated with a combination of surgical resection of the primary tumor, chemotherapy and radiotherapy, depending on the disease stage. Conventional photontherapy nevertheless remains difficult to apply to tumors such as head and neck squamous cell carcinomas (HNSCC), due to...
Uploaded on: December 4, 2022 -
April 18, 2023 (v1)Journal article
The efficacy of anti‐angiogenic treatment by targeting VEGF/VEGF receptors in metastatic clear cell renal cell carcinoma (ccRCC) varies from patient to patient. Discovering the reasons behind this variability could lead to the identification of relevant therapeutic targets. Thus, we investigated the novel splice variants of VEGF that are less...
Uploaded on: October 14, 2023 -
January 2022 (v1)Journal article
Objectives: To investigate the role of cancer-associated fibroblasts (CAFs) in clear cell renal cell carcinoma (ccRCC) with respect to tumour aggressiveness, metastasis development, and resistance to anti-angiogenic therapy (vascular endothelial growth factor receptor-tyrosine kinase inhibitors [VEGFR-TKI]).Patients and methods: Our study...
Uploaded on: December 3, 2022 -
June 2020 (v1)Journal article
This study investigated the relationship of oxytocin (OT) to chondrogenesis and osteoarthritis (OA). Human bone marrow and multipotent adipose-derived stem cells were cultured in vitro in the absence or presence of OT and assayed for mRNA transcript expression along with histological and immunohistochemical analyses. To study the effects of OT...
Uploaded on: December 4, 2022 -
April 30, 2015 (v1)Journal article
Disruption of the endothelial barrier by tumour-derived secreted factors is a critical step in cancer cell extravasation and metastasis. Here, by comparative proteomic analysis of melanoma secretomes, we identify the matricellular protein SPARC as a novel tumour-derived vascular permeability factor. SPARC deficiency abrogates tumour-initiated...
Uploaded on: February 28, 2023 -
September 29, 2017 (v1)Journal article
International audience
Uploaded on: December 4, 2022